| ²é¿´: 390 | »Ø¸´: 20 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
| ¡¾ÐüÉͽð±Ò¡¿»Ø´ð±¾ÌûÎÊÌ⣬×÷Õßchendiqing½«ÔùËÍÄú 30 ¸ö½ð±Ò | |||
chendiqingÌú¸Ëľ³æ (ÖªÃû×÷¼Ò)
|
[ÇóÖú]
²éÎÄÏ×µÄÌâÄ¿£¬Ò»¸ö5½ð±Ò£¬ÄÑÕÒµÄÒ»¸ö10~20½ð±Ò°¡¡¾Òѽâ¾ö£¬Ð»Ð»´ó¼Ò¡¿
|
||
|
¸÷λÐֵܽãÃÃÃÇ£¬°ïæ²éÒ»ÏÂÒÔÏÂÎÄÏ×µÄÌâÄ¿°¡£¬¾ÍÖ»ËüÎÄÏ×µÄÌâÄ¿¾Í¿ÉÒÔÁË£¬ÕÒµ½Ò»¸ö5½ð±Ò£¬ÄÑÕÒµÄÒ»¸ö10~20½ð±Ò²»µÈ£¬°ÝÍÐÁ˰¡~~~~ 1£¬Biginelli , P. Gazz. Chim. Ital . 1893 , 23 , 360. 2£¬Kappe , C. O. Tetrahedron 1993 , 49 , 6937. 3£¬Grover , G. J . ; Dzwonczyk , S. ; McMullen , D. M. ; Grover ,C. S. ; Sleph , P. G. ; Moreland , S. J . J . Cardiovasc. Pharmacol . 1995 , 26 , 289. 4£¬Atwal , K. S. ; Swanson , B. N. ; Unger , S. E. ; Floyd , D. M. ; Moreland , S. ; Hedberg , A. ; O¡äeilly , B. C. J . Med. Chem. 1991 , 34 , 806. 5£¬Rovnyak , G. C. ; Atwal , K. S. ; Hedberg , A. ; Kim2 ball , S. D. ; Moreland , S. ; Gougoutas , J . Z. ; O¡¯eil2ly , B. C. ; Schwartz , J . ; Malley , M. F. J . Med.Chem. 1992 , 35 , 3254. 6£¬Nagarathnam , D. ; Miao , S. W. ; Lagu , B. ; Chiu , G. ; Fang , J . ; MDhar , T. G. ; Zhang , J . ; Tyagarajan , S. ; Marzabadi , M. R. ; Zhang , F. Q. ; Wong , W. C. ; Sun , W. Y. ; Tian , D. ; Wetzel , J . M. ; Forray , C. ; Chang , R. S. L. ;Broten , T. P. ; Ransom , R. W. ;Schorn , T. W. ; Chen , T. B. ; O¡äMalley , S. ;Kling , P. ; Schneck , K. ; Benedesky , R. ; Harrell , C. M. ; Vyas , K. P. ;Gluchowski , C. J . Med. Chem. 1999 , 42 , 4764. 7£¬Barrow , J . C. ; Nantermet , P. G. ; Selnick , H. G. ; Glass , K. L. ; Rittle , K. E. ; Gilbert , K. F. ; Steele , T. G. ; Homnick , C. F. ; Freidinger , R. M. ; Ransom , R. W. ; Kling , P. ; Reiss , D. ; Broten , T. P. ; Schorn , T. W. ; Chang , R. S. L. ; O¡äMalley , S. S. ; Olah , T. V. ; Ellis , J . D. ; Barrish , A. ; Kassahun , K. ; Leppert , P. ; Nagarathnam , D. ; Forray , C. J . Med. Chem. 2000 , 43 , 2703. 8£¬Ma , Y. ; Qian , C. ; Wang , L. ; Yang , M. J . Org. Chem. 2000 , 65 , 3864. 9£¬Ranu , B. C. ; Hajra , A. ; Jana , U. J . Org. Chem. 2000 , 65 , 6270. 10£¬Wipf , P. ; Cunningham , A. Tetrahedron Lett . 1995 , 36 ,7819. 11£¬Studer , A. ; Jeger , P. ; Wipf , P. ; Curran , D. P. J . Org.Chem. 1997 , 62 , 2917. [ Last edited by zzgyb on 2008-7-17 at 10:57 ] |
» ²ÂÄãϲ»¶
Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
277²ÄÁÏ¿ÆÑ§Ó빤³Ì080500Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
ѧУÒѾÌá½»µ½NSFC£¬»¹ÄÜÐÞ¸ÄÂð£¿
ÒѾÓÐ9È˻ظ´
286·ÖÈ˹¤ÖÇÄÜרҵÇëÇóµ÷¼ÁÔ¸Òâ¿ç¿¼£¡
ÒѾÓÐ7È˻ظ´
286Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
280Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
²ÄÁÏѧ˶301·ÖÇóµ÷¼Á
ÒѾÓÐ4È˻ظ´
278Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
ÇóÖú
ÒѾÓÐ5È˻ظ´

zhgyg
Ìú¸Ëľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 5226
- Ìû×Ó: 1000
- ÔÚÏß: 545.1Сʱ
- ³æºÅ: 357006
- ×¢²á: 2007-04-27
- רҵ: ¼ÆËãÊýѧÓë¿ÆÑ§¹¤³Ì¼ÆËã
¡ï ¡ï ¡ï ¡ï ¡ï
chendiqing(½ð±Ò+5,VIP+0):thank you£¬½ð±ÒÇëЦÄÉ£¬ºÇºÇ~~~~
chendiqing(½ð±Ò+5,VIP+0):thank you£¬½ð±ÒÇëЦÄÉ£¬ºÇºÇ~~~~
|
1. Aldehyde-urea derivatives of aceto-and oxaloacetic acids |
2Â¥2008-06-16 22:09:27
zhgyg
Ìú¸Ëľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 5226
- Ìû×Ó: 1000
- ÔÚÏß: 545.1Сʱ
- ³æºÅ: 357006
- ×¢²á: 2007-04-27
- רҵ: ¼ÆËãÊýѧÓë¿ÆÑ§¹¤³Ì¼ÆËã
¡ï ¡ï ¡ï ¡ï ¡ï
chendiqing(½ð±Ò+5,VIP+0):лл°¡£¬½ð±ÒÇëЦÄÉ~~~~~~~
chendiqing(½ð±Ò+5,VIP+0):лл°¡£¬½ð±ÒÇëЦÄÉ~~~~~~~
| 2.100 years of the Biginelli dihydropyrimidine synthesis ¡¶TETRAHEDRON¡· Kappe C O 1993 / 49 / P 6937 |
3Â¥2008-06-16 22:13:01
zhgyg
Ìú¸Ëľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 5226
- Ìû×Ó: 1000
- ÔÚÏß: 545.1Сʱ
- ³æºÅ: 357006
- ×¢²á: 2007-04-27
- רҵ: ¼ÆËãÊýѧÓë¿ÆÑ§¹¤³Ì¼ÆËã
¡ï ¡ï ¡ï ¡ï ¡ï
chendiqing(½ð±Ò+5,VIP+0):ÍÛŶ£¬Ð»Ð»¸çÃÇÄã°¡~~~~
chendiqing(½ð±Ò+5,VIP+0):ÍÛŶ£¬Ð»Ð»¸çÃÇÄã°¡~~~~
|
3.Titre du document / Document title Pharmacologic profile of the dihydropyrimidine calcium channel blockers SQ 32,547 and SQ 32,946 Auteur(s) / Author(s) GROVER G. J. ; DZWONCZYK S. ; MCMULLEN D. M. ; NORMANDIN D. E. ; PARHAM C. S. ; SLEPH P. G. ; MORELAND S. ; Affiliation(s) du ou des auteurs / Author(s) Affiliation(s) Bristol-Myers Squibb pharmaceutical res. inst., dep. pharmacology, Princeton NJ 08543, ETATS-UNIS R¨¦sum¨¦ / Abstract SQ 32,926 and SQ 32,547, two dihydropyrimidine calcium channel blockers, were characterized as potent inhibitors of depolarization-induced contractions of isolated smooth muscle preparations. In rat aorta, the IC50 values were 5.5 nM for SQ 32,547 and 8.1 nM for SQ 32,926, values which compare favorably with that of 2.9 nM for nifedipine. The dihydropyrimidines were also tested in a model of stable angina : pacing-induced ischemia in dogs. Both SQ 32,547 and SQ 32,926 reduced the ST-segment elevation observed in vehicle-treated animals. No significant changes in hemodynamic status were detected, suggesting that a reduction in cardiac work secondary to afterload reduction was probably not a major contributor to the protective effects. Neither was increased coronary blood flow important for the antiischemic outcome because no significant effects of the dihydropyrimidines were observed on ischemic regional blood flow. SQ 32,547 was also studied in globally ischemic, isolated rat hearts. In this model, SQ 32,547 was protective because it significantly reduced contracture formation and lactate dehydrogenase (LDH) release. Washing out the effect of SQ 32,547 in isolated hearts and smooth muscles was difficult, presumably due to its lipophilicity. In the smooth muscle preparations, the effects of both nifedipine and SQ 32,926 were much more easily washed out. As with other calcium channel blockers, increasing the antiischemic effects of SQ 32,547 was associated with a higher cost in terms of cardiac function. In summary, the two novel dihydropyrimidines, SQ 32,547 and SQ 32,926, showed antiischemic properties in animal models. Revue / Journal Title Journal of cardiovascular pharmacology ISSN 0160-2446 CODEN JCPCDT Source / Source 1995, vol. 26, no2, pp. 289-294 (24 ref.) Langue / Language Anglais Editeur / Publisher Lippincott, Hagerstown, MD, ETATS-UNIS (1979) (Revue) Mots-cl¨¦s anglais / English Keywords Calcium antagonist ; Antiïschemic ; Angina pectoris ; Chemotherapy ; Treatment ; Smooth muscle ; Heart ; Rat ; Animal ; In vivo ; In vitro ; Rodentia ; Mammalia ; Vertebrata ; Cardiovascular disease ; Coronary heart disease ; Mots-cl¨¦s français / French Keywords Antagoniste calcium ; Antiisch¨¦mique ; Angine poitrine ; Chimioth¨¦rapie ; Traitement ; Muscle lisse ; Coeur ; Rat ; Animal ; In vivo ; In vitro ; SQ 32 547 ; SQ 32 946 ; Dihydropyrimidine d¨¦riv¨¦ ; Cardioprotecteur ; Rodentia ; Mammalia ; Vertebrata ; Appareil circulatoire pathologie ; Cardiopathie coronaire ; Mots-cl¨¦s espagnols / Spanish Keywords Antagonista calcio ; Antiisqu¨¦mico ; Angina pectoris ; Quimioterapia ; Tratamiento ; M¨²sculo liso ; Coraz¨®n ; Rata ; Animal ; In vivo ; In vitro ; Rodentia ; Mammalia ; Vertebrata ; Aparato circulatorio patolog¨ªa ; Cardiopat¨ªa coronaria ; Localisation / Location INIST-CNRS, Cote INIST : 18065, 35400005361515.0140 |
4Â¥2008-06-16 22:15:46
zhgyg
Ìú¸Ëľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 5226
- Ìû×Ó: 1000
- ÔÚÏß: 545.1Сʱ
- ³æºÅ: 357006
- ×¢²á: 2007-04-27
- רҵ: ¼ÆËãÊýѧÓë¿ÆÑ§¹¤³Ì¼ÆËã
¡ï ¡ï ¡ï ¡ï ¡ï
chendiqing(½ð±Ò+5,VIP+0):ллÁ˰¡~~~~
chendiqing(½ð±Ò+5,VIP+0):ллÁ˰¡~~~~
|
5.Dihydropyrimidine calcium channel blockers. 4. Basic 3-substituted-4-aryl-1, 4-dihydropyrimidine-5 ÎÄÏ×ÏÂÔØµØÖ·£ºhttp://pubs.acs.org/cgi-bin/abst ... 3.pdf?sessid=6006l3 |
5Â¥2008-06-16 22:20:47
fjxin2002
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 2550.7
- É¢½ð: 21
- ºì»¨: 2
- Ìû×Ó: 735
- ÔÚÏß: 24.9Сʱ
- ³æºÅ: 248107
- ×¢²á: 2006-05-03
- ÐÔ±ð: GG
- רҵ: ÄÜÔ´»¯¹¤
¡ï ¡ï ¡ï ¡ï ¡ï
chendiqing(½ð±Ò+5,VIP+0):лл°¡£¬ÐÁ¿àÁË£¬½ð±ÒÇëЦÄÉ~~~~~~~
chendiqing(½ð±Ò+5,VIP+0):лл°¡£¬ÐÁ¿àÁË£¬½ð±ÒÇëЦÄÉ~~~~~~~
| 10. P. Wipf and A. Cunningham, "A Solid Phase Protocol of the Biginelli Dihydropyrimidine Synthesis Suitable for Combinatorial Chemistry", Tetrahedron Lett., 36(43): 7819-7822 (1995 |
6Â¥2008-06-16 22:27:14
zhgyg
Ìú¸Ëľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 5226
- Ìû×Ó: 1000
- ÔÚÏß: 545.1Сʱ
- ³æºÅ: 357006
- ×¢²á: 2007-04-27
- רҵ: ¼ÆËãÊýѧÓë¿ÆÑ§¹¤³Ì¼ÆËã
¡ï ¡ï ¡ï ¡ï ¡ï
chendiqing(½ð±Ò+5,VIP+0):ллŶ~~~
chendiqing(½ð±Ò+5,VIP+0):ллŶ~~~
| 11.Fluorous Synthesis: Fluorous Protocols for the Ugi and Biginelli Multicomponent Condensations |
7Â¥2008-06-16 22:27:50
zhgyg
Ìú¸Ëľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 5226
- Ìû×Ó: 1000
- ÔÚÏß: 545.1Сʱ
- ³æºÅ: 357006
- ×¢²á: 2007-04-27
- רҵ: ¼ÆËãÊýѧÓë¿ÆÑ§¹¤³Ì¼ÆËã
¡ï ¡ï ¡ï ¡ï ¡ï
chendiqing(½ð±Ò+5,VIP+0):лл~~~
chendiqing(½ð±Ò+5,VIP+0):лл~~~
| 9.Indium (III) chloride-catalyzed one-pot synthesis of dihydropyrimidinones by a three-component |
8Â¥2008-06-16 22:28:57
zhgyg
Ìú¸Ëľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 5226
- Ìû×Ó: 1000
- ÔÚÏß: 545.1Сʱ
- ³æºÅ: 357006
- ×¢²á: 2007-04-27
- רҵ: ¼ÆËãÊýѧÓë¿ÆÑ§¹¤³Ì¼ÆËã
¡ï ¡ï ¡ï ¡ï ¡ï
chendiqing(½ð±Ò+5,VIP+0):ÊÕµ½~~~~
chendiqing(½ð±Ò+5,VIP+0):ÊÕµ½~~~~
|
6. Design and Synthesis of Novel 1a Adrenoceptor-Selective Antagonists. 1. Structure-Activity Relationship in Dihydropyrimidinones [ Last edited by zhgyg on 2008-6-16 at 22:35 ] |
9Â¥2008-06-16 22:31:04
fjxin2002
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 2550.7
- É¢½ð: 21
- ºì»¨: 2
- Ìû×Ó: 735
- ÔÚÏß: 24.9Сʱ
- ³æºÅ: 248107
- ×¢²á: 2006-05-03
- ÐÔ±ð: GG
- רҵ: ÄÜÔ´»¯¹¤
¡ï ¡ï ¡ï ¡ï ¡ï
chendiqing(½ð±Ò+5,VIP+0):¶÷£¬Ð»Ð»°¡£¬ËäÈ»ÉÔ΢ÂýÁËÒ»²½£¬µ«½ð±Ò»¹ÊÇÒª¸øÄãµÄ°¡£¬¹þ¹þ¹þ~~~~
chendiqing(½ð±Ò+5,VIP+0):¶÷£¬Ð»Ð»°¡£¬ËäÈ»ÉÔ΢ÂýÁËÒ»²½£¬µ«½ð±Ò»¹ÊÇÒª¸øÄãµÄ°¡£¬¹þ¹þ¹þ~~~~
|
9. Indium(III) Chloride-Catalyzed One-Pot Synthesis of Dihydropyrimidinones by a Three-Component Coupling of 1,3-Dicarbonyl Compounds, Aldehydes, and Urea: An Improved Procedure for the Biginelli Reaction Ranu, B. C.; Hajra, A.; Jana, U. J. Org. Chem.; (Note); 2000; 65(19); 6270-6272. DOI: 10.1021/jo000711f |
10Â¥2008-06-16 22:31:09













»Ø¸´´ËÂ¥